1Amadori A,Zamarchi R,de Silvestro,et al. Genetic control of the CD4/CD8 T-cell ratio in humans[J].Nat Med,1995,1:1279.
2Huygen K, Palfliet K. Strain variation in interferon gramma production of BCG-sensitized mice challenged with PⅡ.Importance of one major antosomal locus and additional sexual influence[J]. Cell Immunol,1984,85:75.
3Chu HY,Shu SG,Mak SC,et al.Graves' disease associated with myasthenia gravis :report of one case[J].Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi,1992,33: 457.
4Marino M, Barbesino G, Pinchera A. Increased frequency of euthyroid ophthalmopathy in patients with Graves' disease associated with myasthenia gravis[J].Thyroid,2000,10:799.
5Gunji K, Skolnick C, Bednarczuk T. Eye muscle antibodies in patients with ocular myasthenia gravis: possible mechanism for eye muscle inflammation in acetylcholine-receptor antibody-negative patients[J].Clin Immunol Immunopathol,1998,87:276.
2Mussi A,Lucchi M,Murri L. Extended thymectomy in myasthenia gravis:a team-work of neurologist,thoracic surgeon and anaesthesist may improve the outcome[J].Eur J Cardiothorae Surg,2001.570.
3Rastenyte D,Vaitkus A,Neverauskas R. Demographic and clinical characteristics of patients with myasthenia gravis[J].Medicina,2002,(06):611-616.
